HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pascale Schumann-Bard Selected Research

Pascale Schumann-Bard Research Topics

Disease

5Stroke (Strokes)
09/2012 - 02/2007
5Hypoxia (Hypoxemia)
04/2012 - 04/2002
5Ischemia
10/2009 - 01/2006
4Brain Ischemia (Cerebral Ischemia)
10/2009 - 04/2002
2Cognitive Dysfunction
10/2021 - 01/2020
1Drug-Related Side Effects and Adverse Reactions
10/2021
1Pain (Aches)
10/2021
1Neuroinflammatory Diseases
09/2012

Drug/Important Bio-Agent (IBA)

4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2012 - 04/2002
4ErythropoietinFDA Link
10/2009 - 04/2002
3Oxygen (Dioxygen)IBA
10/2009 - 01/2006
2Messenger RNA (mRNA)IBA
04/2012 - 04/2002
2AdrenomedullinIBA
04/2012 - 10/2009
2Glucose (Dextrose)FDA LinkGeneric
10/2009 - 04/2006
2Proteins (Proteins, Gene)FDA Link
04/2006 - 04/2002
1Analgesics (Analgesic Drugs)IBA
10/2021
1Tramadol (K315)FDA LinkGeneric
10/2021
1Muscarinic AntagonistsIBA
01/2020
1Cholinergic Antagonists (Anticholinergics)IBA
01/2020
1Nerve Growth Factors (Neurotrophins)IBA
09/2012
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
09/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
09/2012
1Antidepressive Agents (Antidepressants)IBA
09/2012
1Recombinant ProteinsIBA
10/2009
1Neuroprotective AgentsIBA
10/2009
1Deferoxamine (Desferal)FDA LinkGeneric
04/2006
1Chelating AgentsIBA
04/2006
1IronIBA
04/2006
1OligonucleotidesIBA
01/2006

Therapy/Procedure

4Therapeutics
09/2012 - 02/2007
1Ischemic Postconditioning
10/2009
1Intravenous Injections
09/2008